A rare setback as Ozempic-maker Novo Nordisk takes a $820 million hit as its next wonder drug fails
Novo Nordisk A/S said it will take an impairment of about 5.7 billion Danish kroner ($820 million) after halting a ...
Novo Nordisk A/S said it will take an impairment of about 5.7 billion Danish kroner ($820 million) after halting a ...
